TABLE 1.
Basic anthropometric and clinical characteristics of the study groups from two centers
| Characteristics | Delhi |
Pune |
||
|---|---|---|---|---|
| Type 2 diabetic patients | Control subjects | Type 2 diabetic patients | Control subjects | |
| n (men/women) | 1,019 (592/427) | 1,006 (606/400) | 1,467 (826/641) | 1,672 (884/788) |
| Age (years) | 53 (45–62) | 50 (44–60) | 46 (40–52) | 33 (29–37) |
| Age of diagnosis (years) | 45 (39–52) | — | 38.5 (33.3–42.2) | — |
| Individuals on medication for lipids (%) | 4.00 | — | 22.70 | — |
| BMI (kg/m2) | ||||
| Women | 26.70 (24.20–29.20) | 24.90 (21.10–28.60) | 26.90 (24.40–29.60) | 19.53 (17.60–22.74) |
| Men | 23.80 (22.00–26.00) | 23.20 (20.20–25.70) | 24.90 (22.80–27.70) | 21.18 (19.15–23.62) |
| Waist-to-hip ratio | ||||
| Women | 1.00 (0.97–1.03) | 0.86 (0.82–0.92) | 0.89 (0.85–0.94) | 0.76 (0.73–0.80) |
| Men | 1.00 (0.97–1.03) | 0.97 (0.92–1.00) | 0.97 (0.94–1.02) | 0.91 (0.86–0.95) |
| FPG (mmol/l) | 7.90 (6.40–10.30) | 4.90 (4.50–5.30) | 8.50 (6.90–11.30) | 5.11 (4.67–5.56) |
| 2-h PPG (mmol/l) | — | 5.60 (5.80–6.30) | — | 5.50 (4.56–6.50) |
| Total cholesterol (mmol/l) | 4.20 (3.50–5.00) | 4.40 (3.70–5.10) | 4.10 (3.50–4.80) | 3.77 (3.28–4.33) |
| Triglycerides (mmol/l) | 1.60 (1.10–2.20) | 1.30 (1.00–1.80) | 1.40 (1.00–1.20) | 0.84 (0.62–1.20) |
| HDL cholesterol (mmol/l) | 1.03 (0.88–1.22) | 1.06 (0.88–1.28) | 1.03 (0.90–1.18) | 1.03 (0.87–1.23) |
| FPI (pmol/l) | — | 32.20 (17.50–57.20) | — | 32.50 (20.84–49.18) |
| HOMA-IR | — | 1.16 (0.59–2.02) | — | 1.21 (0.76–1.89) |
| HOMA-B | — | 73.40 (40.70–138.60) | — | 69.73 (44.39–109.79) |
Data are median (interquartile range).